Evaluation on the Potential of Ganoderma lucidum Bioactive Compounds as Alpha-Glucosidase Enzyme Inhibitor: A Computational Study

Introduction: Computational simulation study was carried out on bioactive compounds of Ganoderma lucidum (G. lucidum). Methods: Molecular docking and molecular dynamics (MD) simulations were performed. The input files for protein and ligands were retrieved from Protein Data Bank (PDB) and PubChem da...

Full description

Bibliographic Details
Published in:Malaysian Journal of Medicine and Health Sciences
Main Author: Sharif F.; Atan A.K.; Azizan N.H.; Hamid A.A.A.; Ismail C.M.K.H.; Aris M.S.M.
Format: Article
Language:English
Published: Universiti Putra Malaysia Press 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85188672421&doi=10.47836%2fmjmhs.20.2.23&partnerID=40&md5=a85d4a29e9a1cd21e9635d8b93ac30d0
Description
Summary:Introduction: Computational simulation study was carried out on bioactive compounds of Ganoderma lucidum (G. lucidum). Methods: Molecular docking and molecular dynamics (MD) simulations were performed. The input files for protein and ligands were retrieved from Protein Data Bank (PDB) and PubChem database. Human maltase-glucoamylase (PDB ID: 3L4Y) is the protein (α-glucosidase enzyme). The ligands are thirteen compounds derived from G. lucidum together with acarbose and miglitol as controls. Results: Docking result showed the lowest binding energy is from Ganomycin B (-7.8 kcal/mol) compared to acarbose and miglitol (-5.0 kcal/mol and -4.4 kcal/mol) respectively. MD simulation showed interaction of 3L4Y-Ganomycin B achieved stable interaction and conformation as follows: root mean square deviation (RMSD) is ± 2.7 Å, average distance of ±1.8 Å and constant hydrogen bonds around 1 - 3. Conclusion: Ganomycin B was found to have good binding affinity, embarking its potential as a potent α-glucosidase inhibitor. © 2024 Universiti Putra Malaysia Press. All rights reserved.
ISSN:16758544
DOI:10.47836/mjmhs.20.2.23